Evans et al., 1981 - Google Patents

Thymus-dependent membrane antigens in man: inhibition of cell-mediated lympholysis by monoclonal antibodies to TH2 antigen

Evans et al., 1981

View PDF
Document ID
17145197140969862530
Author
Evans R
Wall D
Platsoucas C
Siegal F
Fikrig S
Testa C
Good R
Publication year
Publication venue
Proceedings of the National Academy of Sciences

External Links

Snippet

In prior studies a heteroantiserum to a surface membrane component termed TH2 was used to define two subsets of human T cells (TH2+ and TH2-), which were found to express distinct sets of activities in vitro. In the present studies we prepared monoclonal antibodies to …
Continue reading at www.pnas.org (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material Not used, see subgroups
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Evans et al. Thymus-dependent membrane antigens in man: inhibition of cell-mediated lympholysis by monoclonal antibodies to TH2 antigen
FI75362B (en) FOERFARANDE FOER FRAMSTAELLNING AV EN MONOCLONAL ANTIKROPP MOT MAENNISKANS T-CELLER, MEDELST EN NY HYBRIDCELLINJE.
FI75183C (en) FOERFARANDE FOER FRAMSTAELLNING AV EN KOMPLEMENT-BINDANDE MONOCLONAL ANTIKROPP MOT MAENNISKANS T-CELLER GENOM ANVAENDNING AV EN NY HYBRIDCELLINJE.
Phillips et al. Natural killer cells activated in a human mixed lymphocyte response culture identified by expression of Leu-11 and class II histocompatibility antigens.
CA1170592A (en) Hybrid cell line for producing monoclonal antibody to human helper t cells, antibody, and methods
US5091178A (en) Tumor therapy with biologically active anti-tumor antibodies
FI75365B (en) A FRUIT PROCESSING OF A MONOCLONAL ANTICROPP TO A MAJOR PROTYMOCYTANTIGEN BASED ON A HYBRID CELL.
JPH01501388A (en) In vitro activation of effector cells to kill target cells
Seto et al. In vivo antitumor effects of monoclonal antibodies with different immunoglobulin classes
FI75364C (en) FOERFARANDE FOER FRAMSTAELLNING AV EN MONOCLONAL ANTIKROPP FOER MAENSKLIGA CYTOTOXISKA OCH SUPPRESSOR-T-CELLER MEDELST EN NY HYBRIDCELLINJE.
EP1003547A1 (en) Agonist murine monoclonal antibody as a stimulant for megakaryocytopoiesis
EP0174204B1 (en) Gram-negative bacterial endotoxin blocking monoclonal antibodies and cells producing the same and formulations containing the same, and the production of all thereof
FI75598B (en) FOERFARANDE FOER FRAMSTAELLNING AV EN MONOCLONAL ANTIKROPP MOT EN MAENSKLIG TYMOCYTANTIGEN MEDELST EN NY HYBRIDCELLINJE.
Brett et al. Emergence of CD52−, glycosyiphosphatidylinositol-anchor deficient lymphocytes in rheumatoid arthritis patients following Campath-1H treatment
Kedar et al. Propagation of mouse cytotoxic clones with characteristics of natural killer (NK) cells
WO1986005188A1 (en) Monoclonal antibodies and assay
Wyatt et al. T lymphocyte development in horses I. Characterization of monoclonal antibodies identifying three stages of T lymphocyte differentiation
EP0234122A2 (en) Tumor therapy with biologically active anti-tumor antibodies
Smart et al. Production of a monoclonal allo‐antibody to murine natural cytotoxic cells
US5229494A (en) Receptor for natural killer and non-specific cytotoxic cells
Levine et al. Phenotypic characterization of human bone marrow granulocyte-macrophage forming progenitor cells
TAKADA et al. Novel monoclonal antibody reactive with thrombin-sensitive 74-kDa glycoproteins present on platelets and megakaryocytes both from mouse and rat
Shienvold et al. Human pancreatic cell surface antigens with homologous expression in liver, sweat glands, and other exocrine tissues
Zagury et al. Heterogeneity of human natural killer cells
Couser et al. Summary report: National Institutes of Health conference on monoclonal antibodies in renal research